We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.81B
AUM Growth
+$194M
Cap. Flow
+$40.5M
Cap. Flow %
2.24%
Top 10 Hldgs %
63.7%
Holding
392
New
24
Increased
176
Reduced
102
Closed
74

Top Buys

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$32.5M
2
AMAT icon
Applied Materials
AMAT
+$26.5M
3
AAPL icon
Apple
AAPL
+$13.7M
4
MSFT icon
Microsoft
MSFT
+$11.9M
5
NVDA icon
NVIDIA
NVDA
+$9.49M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$28.3M
2
BEKE icon
KE Holdings
BEKE
+$13.2M
3
TSM icon
TSMC
TSM
+$13.2M
4
ASX icon
ASE Group
ASX
+$7.59M
5
IQ icon
iQIYI
IQ
+$6.13M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.73%
2 Technology 31.74%
3 Communication Services 9.52%
4 Healthcare 5.08%
5 Financials 4.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGNX icon
351
MacroGenics
MGNX
$263M
– –
-16,667
Closed -$245K
MIRM icon
352
Mirum Pharmaceuticals
MIRM
$5.94B
– –
-12,583
Closed -$316K
MOH icon
353
Molina Healthcare
MOH
$10.4B
– –
-546
Closed -$224K
MRSN
354
DELISTED
Mersana Therapeutics
MRSN
– –
-696
Closed -$78K
MYGN icon
355
Myriad Genetics
MYGN
$302M
– –
-11,776
Closed -$251K
OLMA icon
356
Olema Pharmaceuticals
OLMA
$899M
– –
-13,927
Closed -$158K
PHM icon
357
Pultegroup
PHM
$24.5B
– –
-3,104
Closed -$374K
PRTA icon
358
Prothena Corp
PRTA
$479M
– –
-14,340
Closed -$355K
PTCT icon
359
PTC Therapeutics
PTCT
$5.85B
– –
-13,908
Closed -$405K
PTGX icon
360
Protagonist Therapeutics
PTGX
$9.34B
– –
-11,304
Closed -$327K
PVH icon
361
PVH
PVH
$3.49B
– –
-2,888
Closed -$406K
QQQ icon
362
Invesco QQQ Trust
QQQ
$489B
– –
-3,781
Closed -$1.68M
RACE icon
363
Ferrari
RACE
$73.9B
– –
-1,862
Closed -$812K
RCKT icon
364
Rocket Pharmaceuticals
RCKT
$424M
– –
-15,549
Closed -$419K
RCUS icon
365
Arcus Biosciences
RCUS
$3.72B
– –
-16,052
Closed -$303K
REPL icon
366
Replimune Group
REPL
$1.46B
– –
-30,342
Closed -$248K
RMD icon
367
ResMed
RMD
$34.7B
– –
-1,177
Closed -$233K
RYTM icon
368
Rhythm Pharmaceuticals
RYTM
$7.38B
– –
-10,333
Closed -$448K
SAGE
369
DELISTED
Sage Therapeutics
SAGE
– –
-18,544
Closed -$348K
SIRI icon
370
SiriusXM
SIRI
$9.62B
– –
-3,214
Closed -$125K
SLNO
371
DELISTED
Soleno Therapeutics
SLNO
– –
-5,016
Closed -$215K
SRRK icon
372
Scholar Rock
SRRK
$7.04B
– –
-16,339
Closed -$290K
STNG icon
373
Scorpio Tankers
STNG
$3.91B
– –
-3,591
Closed -$257K
TNGX icon
374
Tango Therapeutics
TNGX
$3.94B
– –
-10,398
Closed -$82.6K
TREX icon
375
Trex
TREX
$4.66B
– –
-4,763
Closed -$475K
12 13 14
15
16

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, E Fund Management held 392 positions worth $1.81B, up 12% from $1.61B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

E Fund Management's Q2 2024 filing shows 24 new, 176 increased, 102 reduced and 74 closed positions. Its largest new stake was Futu Holdings: 480,000 shares worth $31.5M. The largest sale was Advanced Micro Devices, an estimated $28.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q2 2024 buy was Futu Holdings: 480,000 shares worth $31.5M.
  • E Fund Management added most to Applied Materials in Q2 2024, an estimated $26.5M increase.
  • E Fund Management's biggest Q2 2024 reduction was Advanced Micro Devices, cutting an estimated $28.3M.
  • E Fund Management fully exited Yum China in Q2 2024, selling an estimated $5.17M.
  • E Fund Management's ten largest holdings make up 64% of its $1.81B portfolio in Q2 2024.
  • E Fund Management opened 24 new positions and closed 74 in Q2 2024.
  • E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.81B.

Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.